Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples

Bioanalysis

Volumn 4, Issue 3, 2012, Pages 237-240

  Meesters, Roland J W ^a   Hooff, Gero P ^a   Gruters, Rob ^a   Van Kampen, Jeroen J A ^a   Luider, Theo M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

antiretroviral protease inhibitor drug; dried blood spots; HIV 1 infection; incurred sample reanalysis; lopinavir; MALDI triple quadrupole MS MS

Indexed keywords

LOPINAVIR; LOPINAVIR PLUS RITONAVIR;

ACCURACY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREDICTION; REPEAT PROCEDURE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ANTI-HIV AGENTS; DRIED BLOOD SPOT TESTING; HIV INFECTIONS; HUMANS; LOPINAVIR; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84856868735     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.328     Document Type: Article

References (18)

1. Burnett JE. Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. Bioanalysis 3(10), 1099-1107 (2011).
2. Pandya HC, Spooner N, Mulla H. Dried blood spots, pharmacokinetic studies and better medicines for children. Bioanalysis 3(7), 779-786 (2011).
3. ter Heine R, Beijnen JH, Huitema AD. Bioanalytical issues in patient-friendly sampling methods for therapeutic drug monitoring: focus on antiretroviral drugs. Bioanalysis 1(7), 1329-1338 (2009).
4. Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays and pitfalls. Ther. Drug Monit. 31(3), 327-336 (2009).
5. O'Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 3(20), 2335-2347 (2011).
6. Meesters R, Hooff G, van Huizen N, Gruters R, Luider T. Impact of internal standard addition on dried blood spot analysis in bioanalytical method development. Bioanalysis 3(20), 2357-2364 (2011).
7. Tan A, Hussain S, Musuku A, Masse R. Internal standard response variations during incurred sample analysis by LC-MS/MS: case by case trouble-shooting. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(27), 3201-3209 (2009).
8. de Boer T, Wieling J. Incurred sample accuracy assessment: design of experiments based on standard addition. Bioanalysis 3(9), 983-992 (2011).
9. Ooms JA, Knegt L, Koster EH. Exploration of a new concept for automated dried blood spot analysis using flow-through desorption and online SPE-MS/MS. Bioanalysis 3(20), 2311-2320 (2011).
10. Barfield M, Ahmad S, Busz M. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples. Bioanalysis 3(9), 1025-1030 (2011).
11. Hoffman D. Statistical considerations for assessment of bioanalytical incurred sample reproducibility. AAPS J. 11(3), 570-580 (2009).
12. Timmerman P, Luedtke S, van Amsterdam P et al. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum. Bioanalysis 1(6), 1049-1056 (2009).
13. Meesters RJ, van Kampen JJ, Reedijk ML et al. Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots. Anal. Bioanal. Chem. 398(1), 319-328 (2010).
14. van Kampen JJ, Reedijk ML, Burgers PC et al. Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry. PloS One 5(7), e11409 (2010).
15. Lytle FE, Julian RK, Tabert AM. Incurred sample reanalysis: enhancing the Bland- Altman approach with tolerance intervals. Bioanalysis 1(4), 705-714 (2009).
16. Altman DG, Bland JM. Measurements in medicine: the analysis of method Comparison Studies. Statistician 32(3), 307-317 (1983).
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476), 307-310 (1986). (Pubitemid 16134762)
18. Li W, Zhang J, Tse FL. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices. Biomed. Chromatogr. 25(1-2), 258-277 (2011).